Neovasc Inc. Cash ROIC

Cash ROIC of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash ROIC growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Cash ROIC for 2021 was -24.89% (a -82.55% decrease from previous year)
  • Annual Cash ROIC for 2020 was -142.64% (a -64.82% decrease from previous year)
  • Annual Cash ROIC for 2019 was -405.41% (a 180.44% increase from previous year)
  • Twelve month Cash ROIC ending March 31, 2022 was -25.79% (a 5.14% increase compared to previous quarter)
  • Twelve month trailing Cash ROIC increased by 11.02% year-over-year
Trailing Cash ROIC for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-25.79% -24.53% -24.61% -23.23%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash ROIC of Neovasc Inc.

Most recent Cash ROICof NVCN including historical data for past 10 years.

Interactive Chart of Cash ROIC of Neovasc Inc.

Neovasc Inc. Cash ROIC for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -24.89%
2020 -142.64%
2019 -405.41%
2018 -144.56%
2017 -13974.64%
2016 -53.4%
2015 -22.12%
2014 -31.76%
2013 -74.64%
2012 -25.68%
2011 -34.38%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.